symbol,statement_type,period_end,line_item,value
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Treasury Shares Number,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,1320421481.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,1320421481.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,43512900000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,48564700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,40386300000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,128457400000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,20307200000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,40386300000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,1362000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,81254700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,113395400000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,81254700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,81254700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,68011200000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,13243500000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,13243500000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,75521200000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,37858500000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,1756100000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tradeand Other Payables Non Current,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Revenue,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,2483500000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,33132300000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,991600000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,32140700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,486600000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,37662700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,2738700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,15432400000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,370400000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,15062000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,428500000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Payables,15433800000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,96100000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,15337700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,156775900000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,98806000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,622600000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,3931300000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Investments,443000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,207000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,207000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Equity Investment,2267900000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investments In Other Ventures Under Equity Method,2267900000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentsin Associatesat Cost,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentsin Subsidiariesat Cost,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,40868400000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,29386300000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,11482100000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,50234900000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,50234900000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,4891200000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,45343700000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Properties,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,57969900000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,5518000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Hedging Assets Current,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Inventory,23127000000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Taxes Receivable,63600000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,23495200000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,5766100000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,2076300000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,3689800000.0
PPLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Treasury Shares Number,4931806.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,1318016324.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,1322948130.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,42020400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,47101600000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,36216000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,124702300000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,10951700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,36216000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,1513000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,79113700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,103951200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,79113700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,79113700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,65884200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,13229500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,13229500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,74004400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,30311400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,1679000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tradeand Other Payables Non Current,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Revenue,1679000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,2291800000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,26017400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,1179900000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,24837500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,323200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,43693000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,417900000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,21084200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,333100000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,20751100000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,2030000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,435700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Payables,16618800000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,832100000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,403000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,15383700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,153118100000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,98473400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,940200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,1148500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,3865000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Investments,349400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,349400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,208300000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,349400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Equity Investment,2053200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investments In Other Ventures Under Equity Method,2053200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentsin Associatesat Cost,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentsin Subsidiariesat Cost,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,42897700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,31672200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,11225500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,48159600000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-23635900000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,71795500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,5657000000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,29600000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,41731800000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,20009600000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,4367500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,54644700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,5110200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Hedging Assets Current,0.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,1257400000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,5086300000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Inventory,21758800000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,4537500000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,5257600000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,11963700000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,162600000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Taxes Receivable,
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,21344300000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-1099300000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,22443600000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,5035300000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,1467100000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,3568200000.0
PPLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,3568200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Treasury Shares Number,4780520.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,1217091928.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,1221872448.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,53091800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,56370800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,23277700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,122782700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,9924300000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,23277700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,1323100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,67735000000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,101570400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,67735000000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,67735000000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,55801800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,11933200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,11933200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,77490600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,39060100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,1755800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tradeand Other Payables Non Current,49800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Revenue,1755800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,2193100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,34854600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,1019200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,33835400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,206800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,38430500000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,255500000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,21516200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,303900000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,21212300000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,2386400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,392100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Payables,12088700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,126200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,35400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,11927100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,145225600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,96870800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,2368700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,3493000000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Investments,417600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,417600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,215500000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,417600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Equity Investment,1701100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investments In Other Ventures Under Equity Method,1701100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentsin Associatesat Cost,
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentsin Subsidiariesat Cost,
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,44457300000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,33382200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,11075100000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,44414400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-19489300000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,63903700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,8529300000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,2254800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,36519400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,16241600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,2613400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,48354800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,5276800000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Hedging Assets Current,231600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,1119700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,5414200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Inventory,16813700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,4461900000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,3347200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,9004600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,185700000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Taxes Receivable,
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,17993400000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-1034200000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,19027600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,6596500000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,4640600000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,1955900000.0
PPLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,1955900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Treasury Shares Number,
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,1216975687.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,1216975687.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,37951800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,41279200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,23608200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,107198800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,10338800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,23608200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,1046400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,66966000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,93187400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,66966000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,66966000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,55106900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,8623800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,37251800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,11859100000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,11859100000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,61004400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,30671000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,1537600000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,107400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tradeand Other Payables Non Current,4000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Revenue,
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,1920100000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,27083400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,862000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,26221400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,125900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,30333400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,374700000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,14195800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,184400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,14011400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,1427900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,338100000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Payables,11220900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,240800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,716600000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,10263500000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,127970400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,87298200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,686900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,892000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,2972700000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Investments,369500000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,955700000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,955700000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Equity Investment,1798200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investments In Other Ventures Under Equity Method,1798200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentsin Associatesat Cost,1056900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentsin Subsidiariesat Cost,24915900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,43357800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,33052800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,10305000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,37157400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-15354400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,52511800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,6731500000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,1785200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,30661700000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,11995900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,1337500000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,40672200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,4629000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Hedging Assets Current,74800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,56200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,4663100000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Inventory,13888000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,3440400000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,3224000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,7223600000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,399600000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Taxes Receivable,
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,17852800000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-545200000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,18398000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,3793900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,1512900000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,2281000000.0
PPLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,2281000000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Treasury Shares Number,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,5690400000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,32494900000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,65900000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tradeand Other Payables Non Current,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Revenue,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,681400000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Payables,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,5937300000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,360300000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Investments,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Equity Investment,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investments In Other Ventures Under Equity Method,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentsin Associatesat Cost,39200000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentsin Subsidiariesat Cost,15876000000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-4374200000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,9679600000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,7381300000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,231100000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Hedging Assets Current,163600000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,56200000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,2440000000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,363800000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,1453900000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,2391100000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,785200000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Taxes Receivable,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-246300000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,8643800000.0
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
PPLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,1467300000.0
